ELTX vs SYF · $132.3M cap vs rev $11.19B
Elicio Therapeutics Inc. (ELTX) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Elicio Therapeutics Inc. (ELTX) is a biotechnology company listed on US.
SYF (SYF) common stock.
ELTX does not have a complete income-statement cache yet.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
ELTX currently screens at market cap $132.3M. SYF currently screens at market cap $0.
Not investment advice. Open the ELTX and SYF stock pages for the full models.
Not investment advice.